Not a good buy right now: price ($14.82 pre-market) is already above JPMorgan’s raised target ($14) while the stock still carries an Underweight rating.
Mixed technicals: bullish moving-average structure but MACD is rolling over (bearish momentum), which is a poor setup for an impatient entry.
Fundamentals are deteriorating (2025/Q3 revenue, earnings, and margins down YoY) with no fresh news catalyst to change the narrative.
Hedge funds are buying aggressively (supportive), but options pricing/volatility looks extreme and volume is thin, reducing signal quality.
Technical Analysis
Trend/Structure: Bullish moving averages (SMA_5 > SMA_20 > SMA_200) suggest the broader trend has been constructive.
Momentum: MACD histogram (-0.0218) is below zero and negatively expanding → bearish momentum building despite the bullish MA stack.
RSI: RSI_6 at 55.4 is neutral; not oversold and not signaling a strong dip-buy.
Key levels: Pivot 14.831 (price ~14.82 is slightly below/at pivot). Near-term support S1 14.415 then S2 14.157; resistance R1 15.247 then R2 15.505.
Pattern-based odds: modest upside bias near-term (next day/week), but negative expected direction over the next month (-1.44%), aligning with weakening momentum.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/Sentiment: Open interest put/call ratio at 0.31 is call-heavy (bullish tilt).
Volume signal quality: Today’s option volume is extremely low (total volume 6; puts 0), so the volume-based put/call signal is not robust.
Volatility: 30D implied volatility is extremely elevated (260.06) versus historical vol (31.48); IV percentile 92 → options are priced for unusually large moves (expensive premium environment).
Activity vs baseline: Open interest today (1,130) is elevated vs average (today vs avg +117.1), suggesting some positioning interest, but without meaningful volume it’s harder to confirm directional conviction.
Technical Summary
Sell
3
Buy
8
Positive Catalysts
suggests market positioning leans bullish.
Neutral/Negative Catalysts
from JPMorgan, with the firm still Underweight—headwind for near-term upside narrative.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: 686,961,158.72, down -4.04% YoY (top-line contraction).
Net income: 16,163,131.81, down -49.13% YoY (sharp profitability drop).
EPS: 0.04, down -55.56% YoY (earnings power weakening).
Gross margin: 42.5, down -1.85% YoY (margin compression trend).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
2026-02-02: JPMorgan raised price target to $14 (from $10) but reiterated Underweight.
Interpretation: target increase acknowledges some improvement vs prior expectations, but the maintained Underweight signals they still see relative downside/limited upside.
Wall Street pro view (pros/cons):
Pros: target raised; could reflect stabilization or better outlook than previously modeled.
Cons: Underweight remains; and with price already above $14, the current setup doesn’t align with that analyst’s risk/reward framing.
Politician/Influential trading: no recent congress trading data available; insiders reported neutral (no significant trend).
Wall Street analysts forecast CCU stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CCU is 11 USD with a low forecast of 11 USD and a high forecast of 11 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast CCU stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CCU is 11 USD with a low forecast of 11 USD and a high forecast of 11 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
0 Hold
1 Sell
Moderate Sell
Current: 14.170
Low
11
Averages
11
High
11
Current: 14.170
Low
11
Averages
11
High
11
JPMorgan
Underweight
maintain
$10 -> $14
AI Analysis
2026-02-02
Reason
JPMorgan
Price Target
$10 -> $14
AI Analysis
2026-02-02
maintain
Underweight
Reason
JPMorgan raised the firm's price target on CCU to $14 from $10 and keeps an Underweight rating on the shares.
Scotiabank
Outperform -> Sector Perform
downgrade
$7,000
2025-05-08
Reason
Scotiabank
Price Target
$7,000
2025-05-08
downgrade
Outperform -> Sector Perform
Reason
Scotiabank downgraded CCU to Sector Perform from Outperform with an unchanged price target of CLP 7,000. CCU reported sales and EBITDA that were roughly in line with consensus, but which "fell quite short of our numbers" and the quality was "low," the analyst tells investors. CCU's numbers were "a significant departure from the excellent posts we've been seeing from other industry peers in the Southern Cone," making the firm think that CCU is losing ground to the competition, the analyst added.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CCU
